These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 795608)

  • 21. Clobazam: uncontrolled and standard controlled clinical trials.
    Ban TA; Amin MM
    Br J Clin Pharmacol; 1979; 7 Suppl 1(Suppl 1):135S-138S. PubMed ID: 35196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dosage schedules in general practice.
    Practitioner; 1970 May; 204(223):719-23. PubMed ID: 4914461
    [No Abstract]   [Full Text] [Related]  

  • 23. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
    Saletu B; Saletu-Zyhlarz G; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
    Neuropsychobiology; 1997; 36(3):130-52. PubMed ID: 9313245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flupenthixol versus combined fluphenazine-nortriptyline in depressive illness.
    Conway JF
    Practitioner; 1981 Mar; 225(1353):400-4. PubMed ID: 7022433
    [No Abstract]   [Full Text] [Related]  

  • 25. Fluphenazine/nortriptyline in the irritable bladder syndrome. A double-blind placebo controlled study.
    Martin MR; Schiff AA
    Br J Urol; 1984 Apr; 56(2):178-9. PubMed ID: 6388713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacological treatment of neurotic depressions].
    Balestra V; Ballardini G; Garello L; Guidi V
    Minerva Med; 1975 Mar; 66(16):759-65. PubMed ID: 1054113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A clinical trial of phenelzine in anxiety depressive and phobic neuroses.
    Mountjoy CQ; Roth M; Garside RF; Leitch IM
    Br J Psychiatry; 1977 Nov; 131():486-92. PubMed ID: 338081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-blind comparative study of desipramine hydrochloride and diazepam in the control of mixed anxiety/depression symptomatology.
    Kleber RJ
    J Clin Psychiatry; 1979 Apr; 40(4):165-70. PubMed ID: 370109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic aspects on once-daily nortriptyline administration.
    Overø KF
    Neuropsychobiology; 1980; 6(1):34-41. PubMed ID: 7366812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nortriptyline-fluphenazine vs. carbamazepine in the symptomatic treatment of diabetic neuropathy.
    Gómez-Pérez FJ; Choza R; Ríos JM; Reza A; Huerta E; Aguilar CA; Rull JA
    Arch Med Res; 1996; 27(4):525-9. PubMed ID: 8987189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preliminary data on the relationship between nortriptyline plasma level and response in depressed children.
    Geller B; Cooper TB; Chestnut EC; Anker JA; Schluchter MD
    Am J Psychiatry; 1986 Oct; 143(10):1283-6. PubMed ID: 3532829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amitriptyline: comparison of three different dosage schedules in neurotic depression.
    De Maio D; Levi-Minzi A
    Br J Psychiatry; 1979 Jul; 135():73-6. PubMed ID: 497630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neuroleptic infusion therapy with high-dosed fluphenazine (author's transl)].
    Fünfgeld EW; Kulhanek F
    Arzneimittelforschung; 1978; 28(9):1489-91. PubMed ID: 383096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychotropics in anxiety and depression--combination or single agent?
    Ucko FA
    Dis Nerv Syst; 1970 Aug; 31(8):539-41. PubMed ID: 4394308
    [No Abstract]   [Full Text] [Related]  

  • 35. Implications of dose regimen and protein binding for plasma nortriptyline estimations.
    Stevenson IH; Wilson NM; Schiff AA
    Neuropharmacology; 1978 Jun; 17(6):423-6. PubMed ID: 673158
    [No Abstract]   [Full Text] [Related]  

  • 36. Oxazepam-protriptyline: a double-blind phase II evaluation of the efficacy and safety of the combination versus placebo in neurotic, depressed and anxious psychiatric outpatients.
    Gilbert MM; Koepke HH
    Curr Ther Res Clin Exp; 1975 Dec; 18(6):825-38. PubMed ID: 813948
    [No Abstract]   [Full Text] [Related]  

  • 37. Plasma drug levels on once-daily dosage.
    Stevenson IH; Schiff AA
    Br Med J; 1977 Aug; 2(6086):579. PubMed ID: 890435
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect on vigilance of a single administration of clobazam].
    Mikus P
    Arzneimittelforschung; 1982; 32(11):1496-501. PubMed ID: 6129858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test.
    Laine K; Tybring G; Härtter S; Andersson K; Svensson JO; Widén J; Bertilsson L
    Clin Pharmacol Ther; 2001 Oct; 70(4):327-35. PubMed ID: 11673748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Fluphenazine as an anxiety-relieving drug. Experiences from its use in general practice].
    Vaglum P
    Tidsskr Nor Laegeforen; 1965 Dec; 85(23):1776-8. PubMed ID: 5326916
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.